At first glance, there seems to be no similarity between the science based pharmaceuticals industry and the fine arts based music industry. Surprisingly, there is one characteristic that makes their business model eerily similar viz intellectual property rights (IPR). Companies of both these industries enjoy tremendous protection from competition due to their invaluable and inviolable IPR.
Related Posts
Is Paytm a Worthy Bet
Stocks Discussion / September 15, 2023 October 11, 2025
Could Biocon Lead a Pharma Rally
Stocks Discussion / September 20, 2023 October 11, 2025
Dreamfolks – Can it be a proxy for high consumer and premiumization spending
Stocks Discussion / October 2, 2023 October 11, 2025
How BSE Is Trying To Regain Its Mojo
Stocks Discussion / October 9, 2023 October 11, 2025
